炎性乳癌 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "炎性乳癌" in Chinese language version.

refsWebsite

Global rank Chinese rank

20nih.gov

4^th place

5^th place

15doi.org

2^nd place

23^rd place

4web.archive.org

1^st place

2semanticscholar.org

11^th place

332^nd place

1cancer.gov

1,684^th place

696^th place

1komen.org

low place

1zenodo.org

621^st place

1,608^th place

1jstor.org

26^th place

113^th place

1ibchelp.org

low place

1umich.edu

459^th place

752^nd place

1handle.net

102^nd place

492^nd place

1archive.org

6^th place

4^th place

1aacrjournals.org

8,869^th place

low place

aacrjournals.org

clincancerres.aacrjournals.org

Lerebours, F; Bertheau, P; Bieche, I; Plassa, L. F; Champeme, M. H; Hacene, K; Toulas, C; Espie, M; Marty, M; Lidereau, R. Two prognostic groups of inflammatory breast cancer have distinct genotypes. Clinical Cancer Research. 2003, 9 (11): 4184–9. PMID 14519644.

archive.org

Palangie, T; Mosseri, V; Mihura, J; Campana, F; Beuzeboc, P; Dorval, T; Garcia-Giralt, E; Jouve, M; Scholl, S; Asselain, B. Prognostic factors in inflammatory breast cancer and therapeutic implications. European Journal of Cancer. 1994, 30A (7): 921–7. PMID 7946584. doi:10.1016/0959-8049(94)90115-5.

cancer.gov

Inflammatory Breast Cancer: Questions and Answers. National Cancer Institute. 15 January 2016 [2 December 2006]. （原始内容存档于2015-02-23）.

doi.org

Wingo, Phyllis A; Jamison, Patricia M; Young, John L; Gargiullo, Paul. Population-Based Statistics for Women Diagnosed with Inflammatory Breast Cancer (United States). Cancer Causes & Control (Submitted manuscript). 2004, 15 (3): 321–8 [2023-01-14]. JSTOR 3554049. PMID 15090727. S2CID 25585518. doi:10.1023/B:CACO.0000024222.61114.18. （原始内容存档于2023-01-14）.
Giordano, Sharon H; Hortobagyi, Gabriel N. Inflammatory breast cancer: Clinical progress and the main problems that must be addressed. Breast Cancer Research. 2003, 5 (6): 284–8. PMC 314400 . PMID 14580242. doi:10.1186/bcr608.
Van Laere, S. J. Nuclear Factor-κB Signature of Inflammatory Breast Cancer by cDNA Microarray Validated by Quantitative Real-time Reverse Transcription-PCR, Immunohistochemistry, and Nuclear Factor-κB DNA-Binding. Clinical Cancer Research. 2006, 12 (11): 3249–56. PMID 16740744. doi:10.1158/1078-0432.CCR-05-2800 .
Van Laere, S J; Van Der Auwera, I; Van Den Eynden, G G; Van Dam, P; Van Marck, E A; Vermeulen, P B; Dirix, L Y. NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. British Journal of Cancer. 2007, 97 (5): 659–69. PMC 2360371 . PMID 17700572. doi:10.1038/sj.bjc.6603906.
Van Der Burg, Bart; Der Saag, Paul T.van. Endocrinology and paracrinology. Molecular Human Reproduction. 1996, 2 (6): 433–8. PMID 9238713. doi:10.1093/molehr/2.6.433 .
Van Den Eynden, Gert G; Van Laere, Steven J; Van Der Auwera, Ilse; Merajver, Sofia D; Van Marck, Eric A; Van Dam, Peter; Vermeulen, Peter B; Dirix, Luc Y; Van Golen, Kenneth L. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer (PDF). Breast Cancer Research and Treatment. 2005, 95 (3): 219–28. PMID 16244790. S2CID 850041. doi:10.1007/s10549-005-9002-1. hdl:2027.42/44235 .
Zhang, D; Lafortune, T. A; Krishnamurthy, S; Esteva, F. J; Cristofanilli, M; Liu, P; Lucci, A; Singh, B; Hung, M.-C; Hortobagyi, G. N; Ueno, N. T. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer. Clinical Cancer Research. 2009, 15 (21): 6639–48. PMC 2783487 . PMID 19825949. doi:10.1158/1078-0432.CCR-09-0951.
Lê, Monique G; Arriagada, Rodrigo; Bahi, Jacqueline; Pfeiffer, Frédérique; Cammoun, Mohamed; Tabbane, Françoise; Rubino, Carole. Are risk factors for breast cancer similar in women with inflammatory breast cancer and in those with non-inflammatory breast cancer?. The Breast. 2006, 15 (3): 355–62. PMID 16198566. doi:10.1016/j.breast.2005.08.018.
Fouad, Tamer M; Kogawa, Takahiro; Reuben, James M; Ueno, Naoto T. The Role of Inflammation in Inflammatory Breast Cancer. Inflammation and Cancer. Advances in Experimental Medicine and Biology 816. 2014: 53–73. ISBN 978-3-0348-0836-1. PMID 24818719. doi:10.1007/978-3-0348-0837-8_3.
Fouad, Tamer M; Kogawa, Takahiro; Liu, Diane D; Shen, Yu; Masuda, Hiroko; El-Zein, Randa; Woodward, Wendy A; Chavez-Macgregor, Mariana; Alvarez, Ricardo H; Arun, Banu; Lucci, Anthony; Krishnamurthy, Savitri; Babiera, Gildy; Buchholz, Thomas A; Valero, Vicente; Ueno, Naoto T. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis. Breast Cancer Research and Treatment. 2015, 152 (2): 407–16. PMC 4492876 . PMID 26017070. doi:10.1007/s10549-015-3436-x.
Yamauchi, H; Woodward, W. A; Valero, V; Alvarez, R. H; Lucci, A; Buchholz, T. A; Iwamoto, T; Krishnamurthy, S; Yang, W; Reuben, J. M; Hortobagyi, G. N; Ueno, N. T. Inflammatory Breast Cancer: What We Know and What We Need to Learn. The Oncologist. 2012, 17 (7): 891–9. PMC 3399643 . PMID 22584436. doi:10.1634/theoncologist.2012-0039.
Yamauchi, Hideko; Ueno, Naoto T. Targeted therapy in inflammatory breast cancer. Cancer. 2010, 116 (11 Suppl): 2758–9. PMID 20503407. doi:10.1002/cncr.25171 .
Rueth, Natasha M; Lin, Heather Y; Bedrosian, Isabelle; Shaitelman, Simona F; Ueno, Naoto T; Shen, Yu; Babiera, Gildy. Underuse of Trimodality Treatment Affects Survival for Patients with Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends from the National Cancer Database. Journal of Clinical Oncology. 2014, 32 (19): 2018–24. PMC 4067942 . PMID 24888808. doi:10.1200/JCO.2014.55.1978.
Masuda, H; Brewer, T. M; Liu, D. D; Iwamoto, T; Shen, Y; Hsu, L; Willey, J. S; Gonzalez-Angulo, A. M; Chavez-Macgregor, M; Fouad, T. M; Woodward, W. A; Reuben, J. M; Valero, V; Alvarez, R. H; Hortobagyi, G. N; Ueno, N. T. Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes. Annals of Oncology. 2014, 25 (2): 384–91. PMC 3905780 . PMID 24351399. doi:10.1093/annonc/mdt525.
Palangie, T; Mosseri, V; Mihura, J; Campana, F; Beuzeboc, P; Dorval, T; Garcia-Giralt, E; Jouve, M; Scholl, S; Asselain, B. Prognostic factors in inflammatory breast cancer and therapeutic implications. European Journal of Cancer. 1994, 30A (7): 921–7. PMID 7946584. doi:10.1016/0959-8049(94)90115-5.

handle.net

hdl.handle.net

Van Den Eynden, Gert G; Van Laere, Steven J; Van Der Auwera, Ilse; Merajver, Sofia D; Van Marck, Eric A; Van Dam, Peter; Vermeulen, Peter B; Dirix, Luc Y; Van Golen, Kenneth L. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer (PDF). Breast Cancer Research and Treatment. 2005, 95 (3): 219–28. PMID 16244790. S2CID 850041. doi:10.1007/s10549-005-9002-1. hdl:2027.42/44235 .

ibchelp.org

"Inflammatory Breast Cancer Help—Signs and Symptoms." Inflammatory Breast Cancer Association. 2 April 2009 <http://www.ibchelp.org/symptoms/ （页面存档备份，存于互联网档案馆）>

jstor.org

Wingo, Phyllis A; Jamison, Patricia M; Young, John L; Gargiullo, Paul. Population-Based Statistics for Women Diagnosed with Inflammatory Breast Cancer (United States). Cancer Causes & Control (Submitted manuscript). 2004, 15 (3): 321–8 [2023-01-14]. JSTOR 3554049. PMID 15090727. S2CID 25585518. doi:10.1023/B:CACO.0000024222.61114.18. （原始内容存档于2023-01-14）.

komen.org

ww5.komen.org

Facts for Life - Inflammatory Breast Cancer (PDF). Susan G. Komen for the Cure. [2 December 2006]. （原始内容 (PDF)存档于2009-02-06）.

nih.gov

ncbi.nlm.nih.gov

Nofal MN, Yousef AJ. The diagnosis of male breast cancer. The Netherlands Journal of Medicine. December 2019, 77 (10): 356–359. PMID 31880271.
Wingo, Phyllis A; Jamison, Patricia M; Young, John L; Gargiullo, Paul. Population-Based Statistics for Women Diagnosed with Inflammatory Breast Cancer (United States). Cancer Causes & Control (Submitted manuscript). 2004, 15 (3): 321–8 [2023-01-14]. JSTOR 3554049. PMID 15090727. S2CID 25585518. doi:10.1023/B:CACO.0000024222.61114.18. （原始内容存档于2023-01-14）.
Gordon, L. Inflammatory breast cancer. Clinical Journal of Oncology Nursing. 2001, 5 (4): 175–6. PMID 12690620.
Giordano, Sharon H; Hortobagyi, Gabriel N. Inflammatory breast cancer: Clinical progress and the main problems that must be addressed. Breast Cancer Research. 2003, 5 (6): 284–8. PMC 314400 . PMID 14580242. doi:10.1186/bcr608.
Kusama, M; Koyanagi, Y; Sekine, M; Serizawa, H; Ebihara, Y; Hirota, T; Nakamura, Y; Matsunaga, T. A case of inflammatory breast cancer successfully treated with 5'-DFUR and MPA. Gan to Kagaku Ryoho. Cancer & Chemotherapy. 1994, 21 (12): 2049–52. PMID 8085857.
Yamada, T; Okazaki, M; Okazaki, A; Sato, H; Watanabe, Y; Toda, K; Okazaki, Y; Asaishi, K; Hirata, K; Narimatsu, E. A case of inflammatory breast cancer treated with medroxyprogesterone acetate (MPA) in combination with intra-arterial infusion chemotherapy. Gan to Kagaku Ryoho. Cancer & Chemotherapy. 1992, 19 (11): 1923–5. PMID 1387777.
Van Laere, S. J. Nuclear Factor-κB Signature of Inflammatory Breast Cancer by cDNA Microarray Validated by Quantitative Real-time Reverse Transcription-PCR, Immunohistochemistry, and Nuclear Factor-κB DNA-Binding. Clinical Cancer Research. 2006, 12 (11): 3249–56. PMID 16740744. doi:10.1158/1078-0432.CCR-05-2800 .
Van Laere, S J; Van Der Auwera, I; Van Den Eynden, G G; Van Dam, P; Van Marck, E A; Vermeulen, P B; Dirix, L Y. NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. British Journal of Cancer. 2007, 97 (5): 659–69. PMC 2360371 . PMID 17700572. doi:10.1038/sj.bjc.6603906.
Van Der Burg, Bart; Der Saag, Paul T.van. Endocrinology and paracrinology. Molecular Human Reproduction. 1996, 2 (6): 433–8. PMID 9238713. doi:10.1093/molehr/2.6.433 .
Van Den Eynden, Gert G; Van Laere, Steven J; Van Der Auwera, Ilse; Merajver, Sofia D; Van Marck, Eric A; Van Dam, Peter; Vermeulen, Peter B; Dirix, Luc Y; Van Golen, Kenneth L. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer (PDF). Breast Cancer Research and Treatment. 2005, 95 (3): 219–28. PMID 16244790. S2CID 850041. doi:10.1007/s10549-005-9002-1. hdl:2027.42/44235 .
Zhang, D; Lafortune, T. A; Krishnamurthy, S; Esteva, F. J; Cristofanilli, M; Liu, P; Lucci, A; Singh, B; Hung, M.-C; Hortobagyi, G. N; Ueno, N. T. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer. Clinical Cancer Research. 2009, 15 (21): 6639–48. PMC 2783487 . PMID 19825949. doi:10.1158/1078-0432.CCR-09-0951.
Lê, Monique G; Arriagada, Rodrigo; Bahi, Jacqueline; Pfeiffer, Frédérique; Cammoun, Mohamed; Tabbane, Françoise; Rubino, Carole. Are risk factors for breast cancer similar in women with inflammatory breast cancer and in those with non-inflammatory breast cancer?. The Breast. 2006, 15 (3): 355–62. PMID 16198566. doi:10.1016/j.breast.2005.08.018.
Fouad, Tamer M; Kogawa, Takahiro; Reuben, James M; Ueno, Naoto T. The Role of Inflammation in Inflammatory Breast Cancer. Inflammation and Cancer. Advances in Experimental Medicine and Biology 816. 2014: 53–73. ISBN 978-3-0348-0836-1. PMID 24818719. doi:10.1007/978-3-0348-0837-8_3.
Fouad, Tamer M; Kogawa, Takahiro; Liu, Diane D; Shen, Yu; Masuda, Hiroko; El-Zein, Randa; Woodward, Wendy A; Chavez-Macgregor, Mariana; Alvarez, Ricardo H; Arun, Banu; Lucci, Anthony; Krishnamurthy, Savitri; Babiera, Gildy; Buchholz, Thomas A; Valero, Vicente; Ueno, Naoto T. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis. Breast Cancer Research and Treatment. 2015, 152 (2): 407–16. PMC 4492876 . PMID 26017070. doi:10.1007/s10549-015-3436-x.
Yamauchi, H; Woodward, W. A; Valero, V; Alvarez, R. H; Lucci, A; Buchholz, T. A; Iwamoto, T; Krishnamurthy, S; Yang, W; Reuben, J. M; Hortobagyi, G. N; Ueno, N. T. Inflammatory Breast Cancer: What We Know and What We Need to Learn. The Oncologist. 2012, 17 (7): 891–9. PMC 3399643 . PMID 22584436. doi:10.1634/theoncologist.2012-0039.
Yamauchi, Hideko; Ueno, Naoto T. Targeted therapy in inflammatory breast cancer. Cancer. 2010, 116 (11 Suppl): 2758–9. PMID 20503407. doi:10.1002/cncr.25171 .
Rueth, Natasha M; Lin, Heather Y; Bedrosian, Isabelle; Shaitelman, Simona F; Ueno, Naoto T; Shen, Yu; Babiera, Gildy. Underuse of Trimodality Treatment Affects Survival for Patients with Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends from the National Cancer Database. Journal of Clinical Oncology. 2014, 32 (19): 2018–24. PMC 4067942 . PMID 24888808. doi:10.1200/JCO.2014.55.1978.
Masuda, H; Brewer, T. M; Liu, D. D; Iwamoto, T; Shen, Y; Hsu, L; Willey, J. S; Gonzalez-Angulo, A. M; Chavez-Macgregor, M; Fouad, T. M; Woodward, W. A; Reuben, J. M; Valero, V; Alvarez, R. H; Hortobagyi, G. N; Ueno, N. T. Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes. Annals of Oncology. 2014, 25 (2): 384–91. PMC 3905780 . PMID 24351399. doi:10.1093/annonc/mdt525.
Palangie, T; Mosseri, V; Mihura, J; Campana, F; Beuzeboc, P; Dorval, T; Garcia-Giralt, E; Jouve, M; Scholl, S; Asselain, B. Prognostic factors in inflammatory breast cancer and therapeutic implications. European Journal of Cancer. 1994, 30A (7): 921–7. PMID 7946584. doi:10.1016/0959-8049(94)90115-5.
Lerebours, F; Bertheau, P; Bieche, I; Plassa, L. F; Champeme, M. H; Hacene, K; Toulas, C; Espie, M; Marty, M; Lidereau, R. Two prognostic groups of inflammatory breast cancer have distinct genotypes. Clinical Cancer Research. 2003, 9 (11): 4184–9. PMID 14519644.

semanticscholar.org

api.semanticscholar.org

Wingo, Phyllis A; Jamison, Patricia M; Young, John L; Gargiullo, Paul. Population-Based Statistics for Women Diagnosed with Inflammatory Breast Cancer (United States). Cancer Causes & Control (Submitted manuscript). 2004, 15 (3): 321–8 [2023-01-14]. JSTOR 3554049. PMID 15090727. S2CID 25585518. doi:10.1023/B:CACO.0000024222.61114.18. （原始内容存档于2023-01-14）.
Van Den Eynden, Gert G; Van Laere, Steven J; Van Der Auwera, Ilse; Merajver, Sofia D; Van Marck, Eric A; Van Dam, Peter; Vermeulen, Peter B; Dirix, Luc Y; Van Golen, Kenneth L. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer (PDF). Breast Cancer Research and Treatment. 2005, 95 (3): 219–28. PMID 16244790. S2CID 850041. doi:10.1007/s10549-005-9002-1. hdl:2027.42/44235 .

umich.edu

deepblue.lib.umich.edu

Van Den Eynden, Gert G; Van Laere, Steven J; Van Der Auwera, Ilse; Merajver, Sofia D; Van Marck, Eric A; Van Dam, Peter; Vermeulen, Peter B; Dirix, Luc Y; Van Golen, Kenneth L. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer (PDF). Breast Cancer Research and Treatment. 2005, 95 (3): 219–28. PMID 16244790. S2CID 850041. doi:10.1007/s10549-005-9002-1. hdl:2027.42/44235 .

web.archive.org

Inflammatory Breast Cancer: Questions and Answers. National Cancer Institute. 15 January 2016 [2 December 2006]. （原始内容存档于2015-02-23）.
Facts for Life - Inflammatory Breast Cancer (PDF). Susan G. Komen for the Cure. [2 December 2006]. （原始内容 (PDF)存档于2009-02-06）.
Wingo, Phyllis A; Jamison, Patricia M; Young, John L; Gargiullo, Paul. Population-Based Statistics for Women Diagnosed with Inflammatory Breast Cancer (United States). Cancer Causes & Control (Submitted manuscript). 2004, 15 (3): 321–8 [2023-01-14]. JSTOR 3554049. PMID 15090727. S2CID 25585518. doi:10.1023/B:CACO.0000024222.61114.18. （原始内容存档于2023-01-14）.
"Inflammatory Breast Cancer Help—Signs and Symptoms." Inflammatory Breast Cancer Association. 2 April 2009 <http://www.ibchelp.org/symptoms/ （页面存档备份，存于互联网档案馆）>

zenodo.org

Wingo, Phyllis A; Jamison, Patricia M; Young, John L; Gargiullo, Paul. Population-Based Statistics for Women Diagnosed with Inflammatory Breast Cancer (United States). Cancer Causes & Control (Submitted manuscript). 2004, 15 (3): 321–8 [2023-01-14]. JSTOR 3554049. PMID 15090727. S2CID 25585518. doi:10.1023/B:CACO.0000024222.61114.18. （原始内容存档于2023-01-14）.